Most North American pharmaceutical companies measure commercial performance at the territory or regional level. While useful, this approach often hides where growth is really happening. Brick-level sales analytics provides a much more granular view, enabling commercial teams to understand performance at the smallest actionable geographic level.

What Is Brick-Level Sales Performance in Pharma?

A brick is a standardized geographic unit used to measure pharmaceutical sales, prescribing activity, and market performance. Multiple bricks make up a territory, while multiple territories form a region.

Unlike territory-level reporting, brick-level data helps commercial teams answer questions such as:

• Which local markets are underperforming?
• Where are competitors gaining share?
• Which bricks offer the highest growth potential?

This level of pharma sales data granularity enables better commercial decisions than relying solely on regional averages.

The Commercial Challenge: Field Force Activity vs. Brick Results

Many commercial teams invest heavily in field visits but struggle to connect activity with localized revenue growth.

Common challenges include:

• Sales representatives visiting the same healthcare professionals across overlapping routes.
• High travel and transportation costs.
• Limited visibility into whether field activities actually improve sales within specific bricks.
• CRM data existing separately from syndicated sales reporting.

Without integrated brick level sales data in a pharma CRM, commercial leaders cannot confidently measure field force ROI.

Brick-Level Data vs. Territory-Level Pharma Sales

Traditional territory reports provide a broad performance snapshot.

Brick-level analytics goes further by identifying:

• High-growth neighborhoods
• Under-served HCP clusters
• Local prescribing trends
• Emerging competitive threats

Whether analyzing sub-national pharma sales data in Canada or pharma sales territory data across US, commercial teams gain far greater precision.

How PharmaServ Transforms Brick Data into Actionable Strategy

PharmaServ combines CRM activity with brick-level market intelligence to help commercial teams make smarter decisions.

Using HCP segmentation with brick data, organizations can:

• Prioritize high-value physicians
• Optimize representative routing
• Reduce duplicate visits
• Improve sell-in and sell-out tracking
• Monitor field performance at the brick level

Instead of static reports, PharmaServ delivers actionable recommendations that improve territory coverage and maximize field productivity.

For companies looking for an affordable brick-level data alternative to IQVIA, PharmaServ provides an integrated platform that combines CRM workflows, commercial analytics, and AI-powered insights into a single solution.

Frequently Asked Questions

How do you use brick-level data without IQVIA?

Organizations can combine CRM engagement, pharmacy sales, distributor data, and regional market intelligence within PharmaServ to create localized performance dashboards without relying exclusively on syndicated data.

What is the difference between brick-level and territory-level reporting?

Brick-level reporting measures performance within small geographic areas, while territory reporting aggregates multiple bricks. Brick analytics reveals localized opportunities that territory averages often conceal.

What is the best CRM for brick-level pharma sales in Canada and North America?

Commercial teams operating across Canada and other North American markets require CRM platforms that integrate territory management, HCP engagement, routing, and localized sales analytics. PharmaServ delivers these capabilities in a unified commercial platform.

Conclusion

Commercial excellence starts with better visibility. By combining brick-level sales reporting, AI-driven HCP insights, and territory optimization, pharmaceutical companies can improve field force efficiency, reduce operating costs, and accelerate revenue growth.

With PharmaServ, commercial leaders move beyond regional reporting to understand where growth happens, why it happens, and what action to take next, turning brick-level insights into measurable business outcomes.